
GenMark Diagnostics, Inc. GNMK
GenMark Diagnostics, Inc. DPO Ratio 2011-2026 | GNMK
Annual DPO Ratio GenMark Diagnostics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 81.3 | 75.2 | 70.4 | 125 | 161 | 104 | 96.4 | 88.7 | 76.7 | 70.6 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 161 | 70.4 | 95 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
ClearPoint Neuro
CLPT
|
33.2 | $ 11.1 | -0.72 % | $ 314 M | ||
|
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | ||
|
Electromed
ELMD
|
47.8 | $ 25.81 | 0.98 % | $ 218 M | ||
|
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | ||
|
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M | ||
|
Eargo
EAR
|
124 | - | - | $ 10.2 M | ||
|
Helius Medical Technologies
HSDT
|
362 | $ 2.16 | - | $ 1.31 M | ||
|
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | ||
|
Second Sight Medical Products
EYES
|
29.6 | - | -0.97 % | $ 54.4 M | ||
|
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | ||
|
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.45 | 3.29 % | $ 129 M | ||
|
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | ||
|
Cytosorbents Corporation
CTSO
|
107 | $ 0.61 | -2.42 % | $ 38 M | ||
|
Delcath Systems
DCTH
|
56 | $ 11.53 | 4.63 % | $ 413 M | ||
|
LivaNova PLC
LIVN
|
68 | $ 57.59 | -2.51 % | $ 3.14 B | ||
|
LENSAR
LNSR
|
146 | $ 5.48 | -1.44 % | $ 65.5 M | ||
|
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | ||
|
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | ||
|
Invacare Corporation
IVC
|
75.6 | - | - | $ 24.7 M | ||
|
Insulet Corporation
PODD
|
22.5 | $ 167.53 | -2.25 % | $ 11.8 B | ||
|
Inspire Medical Systems
INSP
|
103 | $ 48.25 | -12.02 % | $ 1.42 B | ||
|
IRIDEX Corporation
IRIX
|
71.9 | $ 1.05 | -3.23 % | $ 17.8 M | ||
|
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B | ||
|
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | ||
|
Sintx Technologies
SINT
|
223 | $ 2.42 | - | $ 6.71 M | ||
|
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
48.6 | - | - | $ 111 M | ||
|
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 17.04 | 7.98 % | $ 400 M | ||
|
Butterfly Network
BFLY
|
51.3 | $ 4.82 | -0.52 % | $ 1.02 B | ||
|
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | ||
|
TransMedics Group
TMDX
|
15.5 | $ 94.93 | -2.21 % | $ 3.23 B | ||
|
Tandem Diabetes Care
TNDM
|
35.7 | $ 19.42 | -2.26 % | $ 1.32 B | ||
|
Globus Medical
GMED
|
33.1 | $ 90.03 | -0.63 % | $ 12.2 B | ||
|
NanoVibronix
NAOV
|
58.2 | - | - | $ 1.08 M | ||
|
CONMED Corporation
CNMD
|
57.3 | $ 36.64 | 2.12 % | $ 1.14 B | ||
|
Stryker Corporation
SYK
|
70.1 | $ 295.25 | 1.5 % | $ 113 B | ||
|
Integer Holdings Corporation
ITGR
|
28.9 | $ 85.85 | 2.26 % | $ 2.98 B | ||
|
Edwards Lifesciences Corporation
EW
|
58.1 | $ 82.91 | -0.5 % | $ 48.5 B | ||
|
Pulmonx Corporation
LUNG
|
60.4 | $ 1.27 | -4.51 % | $ 51.7 M | ||
|
MiMedx Group
MDXG
|
54.8 | $ 3.64 | 0.83 % | $ 538 M | ||
|
Myomo
MYO
|
34.8 | $ 0.88 | 1.69 % | $ 36.8 M |